Wallace L. Hall Jr.

CIK: 0001762801

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TVRD

Tvardi Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

TVRD
Tvardi Therapeutics, Inc.
Jun 9, 2026
Award(A)
Stock Option (right to buy)
Direct
6K shares-
TVRD
Tvardi Therapeutics, Inc.
Apr 17, 2025
Award(A)
Stock Option (right to buy)
Direct
12K shares-
TVRD
Tvardi Therapeutics, Inc.
Apr 15, 2025
Award(A)
Indirect
44.7K shares-
TVRD
Tvardi Therapeutics, Inc.
Apr 15, 2025
Award(A)
Indirect
202K shares-
TVRD
Tvardi Therapeutics, Inc.
Apr 15, 2025
Other(J)
Indirect
44.7K shares-
TVRD
Tvardi Therapeutics, Inc.
Apr 15, 2025
Other(J)
Indirect
202K shares-

		Type	Shares	Price		Ownership
Jun 9, 2026	TVRD Tvardi Therapeutics, Inc.	Award(A) Stock Option (right to buy)	6,000	-	-	Direct
Apr 17, 2025	TVRD Tvardi Therapeutics, Inc.	Award(A) Stock Option (right to buy)	12,000	-	-	Direct
Apr 15, 2025	TVRD Tvardi Therapeutics, Inc.	Award(A)	44,712	-	-	Indirect
Apr 15, 2025	TVRD Tvardi Therapeutics, Inc.	Award(A)	202,044	-	-	Indirect
Apr 15, 2025	TVRD Tvardi Therapeutics, Inc.	Other(J)	44,712	-	-	Indirect
Apr 15, 2025	TVRD Tvardi Therapeutics, Inc.	Other(J)	202,044	-	-	Indirect

1-6 of 6 transactions

About HALL WALLACE L JR

HALL WALLACE L JR (SEC CIK 0001762801) files insider reports with the SEC as Director of Tvardi Therapeutics, Inc. (TVRD).

Signal8 holds 5 ownership filings by HALL WALLACE L JR (1 Form 3, 4 Form 4), filed between Apr 17, 2025 and Jun 11, 2026. Those filings report 6 transactions, from Apr 15, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on HALL WALLACE L JR's filings is in SUGAR LAND, TX.

Recent filings by HALL WALLACE L JR

Jun 9, 2026: Grant or award of TVRD derivative securities (Form 4, code A).
Apr 17, 2025: Grant or award of TVRD derivative securities (Form 4, code A).
Apr 15, 2025: Grants or awards of TVRD shares (2 lines, Form 4, code A).
Apr 15, 2025: Other transactions of TVRD shares (2 lines, Form 4, code J).

Other insiders filing for Tvardi Therapeutics, Inc. (TVRD)

Shiff Susan Ph.D., Director
Smith Cynthia, Director
Shah Sujal, Director
WYZGA MICHAEL S, Director
O'Brien Stephen Paul, Principal Accounting Officer
Conn Avi Daniel, Chief Financial Officer

How to read Form 4 transaction codes